Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1995-01-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00002A014PMID 7830275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors.

  1993cited by this paper
• Images of estrogen-receptor-positive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha.

  1993cited by this paper
• 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.

  1993cited by this paper
• Progestin 16 alpha, 17 alpha-dioxolane ketals as molecular probes for the progesterone receptor: synthesis, binding affinity, and photochemical evaluation.

  1993cited by this paper
• Fluorine-substituted corticosteroids: synthesis and evaluation as potential receptor-based imaging agents for positron emission tomography of the brain.

  1992cited by this paper
• [Tumor scintigraphy using 123I-labeled estradiol in breast cancer--receptor scintigraphy].

  1991cited by this paper
• Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.

  1991cited by this paper
• Breast cancer: PET imaging of estrogen receptors.

  1988cited by this paper
• Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time

  1988cited by this paper
• A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.

  1988cited by this paper
• 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.

  1988cited by this paper
• Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate.

  1988cited by this paper
• Relationship of Estrogen and Progesterone Receptors to Prognosis in Breast Cancer

  1988cited by this paper
• Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment.

  1987cited by this paper
• Fluorinated androgens and progestins: molecular probes for androgen and progesterone receptors with potential use in positron emission tomography.

  1987cited by this paper
• Synthesis and evaluation of potential radioligands for the progesterone receptor.

  1985cited by this paper
• An improved [18O]water target for [18F]fluoride production.

  1985cited by this paper
• The pharmacology and clinical uses of tamoxifen.

  1984cited by this paper
• Steroid hormone receptors in human breast cancer.

  1983cited by this paper
• Molecular interactions of progesterone analogues with rabbit uterine cytoplasmic receptor.

  1982cited by this paper
• Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.

  1980cited by this paper
• Steroid Hormone Receptors and Disease: Breast Cancer

  1979cited by this paper
• Synthesis of fluorine-18 labeled 21-fluoroprogesterone.

  1977cited by this paper
• [New methods for the preparation of 21-fluoro-steroids (author's transl)].

  1976cited by this paper
• Metabolism of megestrol acetate and related progesterone analogues by liver preparations in vitro.

  1965cited by this paper
• Biological activities of 16 alpha, 17 alpha dihydroxyprogesterone derivatives.

  1961cited by this paper

• Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress

  2024cites this paper
• Molecular Imaging of Steroid Receptors in Breast Cancer.

  2024cites this paper
• Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154

  2024cites this paper
• Zinc-Mediated Radiosynthesis of Unprotected Fluorine-18 Labelled α-Tertiary Amides.

  2023cites this paper
• Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review

  2022cites this paper
• Nuclear Receptor Imaging In Vivo—Clinical and Research Advances

  2022cites this paper
• In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography.

  2021cites this paper
• Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

  2021cites this paper
• PET and SPECT Imaging of Steroid Hormone Receptors in the Brain

  2020cites this paper
• PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging

  2020influential citation
• The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

  2020cites this paper
• Fluorine-18 Labeled Fluorofuranylnorprogesterone ([18F]FFNP) and Dihydrotestosterone ([18F]FDHT) Prepared by “Fluorination on Sep-Pak” Method

  2019cites this paper
• Measuring Estrogen Receptor Functionality Using Progesterone Receptor PET Imaging: Rising to the (Estradiol) Challenge!

  2018cites this paper
• Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

  2018cites this paper
• Sensitivity and Isoform Specificity of 18F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer

  2018cites this paper
• University of Groningen PET imaging of brain sex steroid hormone receptors and the role of estrogen in depression

  2017cites this paper
• Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer

  2016cites this paper
• Small Molecules for Active Targeting in Cancer

  2016cites this paper
• Synthesis and pre-clinical evaluation of a [18F]fluoromethyl-tanaproget derivative for imaging of progesterone receptor expression

  2016cites this paper
• Molecular imaging using PET and SPECT for identification of breast cancer subtypes

  2016cites this paper
• University of Groningen PET imaging of brain sex steroid hormone receptors and the role of estrogen in depression Khayum,

  2015cites this paper
• PET imaging of brain sex steroid hormone receptors and the role of estrogen in depression

  2015cites this paper
• PET Imaging of Steroid Hormone Receptor Expression

  2015cites this paper
• Longitudinal Noninvasive Imaging of Progesterone Receptor as a Predictive Biomarker of Tumor Responsiveness to Estrogen Deprivation Therapy

  2014cites this paper
• Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.

  2014cites this paper
• PET and SPECT Imaging of Steroid Hormone Receptors

  2014cites this paper
• Steroid receptor ligands for breast cancer targeting: an insight into their potential role as PET imaging agents.

  2013cites this paper
• Molecular pathways and molecular imaging in breast cancer: an update.

  2013cites this paper
• Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy.

  2013cites this paper
• Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer

  2012cites this paper
• Positron emission tomography radiopharmaceuticals for sex steroid hormone receptor imaging.

  2012cites this paper
• Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione

  2012cites this paper
• Steroid receptor ligands for breast cancer targeting: an insight into their potential role as PET imaging agents

  2012cites this paper
• Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

  2010cites this paper
• Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.

  2010cites this paper
• Synthesis, in vitro progesterone receptors affinity of gadolinium containing mifepristone conjugates and estimation of binding sites in human breast cancer cells.

  2010cites this paper
• Steroid receptors as molecular targets for cancer diagnosis and therapy.

  2009cites this paper
• Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.

  2008cites this paper
• PET imaging of steroid receptor expression in breast and prostate cancer.

  2008cites this paper
• Nuclear imaging of hormonal receptor status in breast cancer: a tool for guiding endocrine treatment and drug development.

  2007cites this paper
• Bromine- and iodine-substituted 16alpha,17alpha-dioxolane progestins for breast tumor imaging and radiotherapy: synthesis and receptor binding affinity.

  2006cites this paper
• Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor.

  2006cites this paper
• Fluorinated tracers for imaging cancer with positron emission tomography

  2004cites this paper
• A novel, high-affinity, fluorescent progesterone receptor antagonist. Synthesis and in vitro studies.

  2004cites this paper
• Assessment of Cancer-Associated Biomarkers by Positron Emission Tomography: Advances and Challenges

  2003cites this paper
• Predicting the success of a radiopharmaceutical for in vivo imaging of central nervous system neuroreceptor systems.

  2003cites this paper
• Pharmacodynamics of radiolabelled anticancer drugs for positron emission tomography.

  2003cites this paper
• Positron emission tomography scanning in gynecologic and breast cancers

  2003cites this paper
• PET for in vivo pharmacokinetic and pharmacodynamic measurements.

  2002cites this paper
• TUMOR IMAGING APPLICATIONS IN THE TESTING OF NEW DRUGS

  2002cites this paper
• An efficient route for the preparation of a 21-fluoro progestin-16 alpha,17 alpha-dioxolane, a high-affinity ligand for PET imaging of the progesterone receptor.

  2002cites this paper
• Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET.

  2001cites this paper
• Improved labeling procedure of [18F]FFNP for in vivo imaging of progesterone receptors

  2001cites this paper
• Steroids Labeled with 18F for Imaging Tumors by Positron Emission Tomography

  2001cites this paper
• Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

  2000cites this paper
• Radiochemical synthesis and tissue distribution of Tc-99m-labeled 7alpha-substituted estradiol complexes.

  2000cites this paper
• Integrated "3+1" oxorhenium(V) complexes as estrogen mimics.

  1999cites this paper
• Synthesis and Binding Affinities of Novel Re-Containing 7alpha-Substituted Estradiol Complexes: Models for Breast Cancer Imaging Agents.

  1999cites this paper
• New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 1: Synthesis and in vitro pharmacological characterization.

  1998cites this paper
• PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.

  1998cites this paper
• Syntheses of [21-11C] and (21-13C)progesterone

  1997cites this paper
• Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results.

  1997cites this paper
• Estrogen and Progestin Radiopharmaceuticals for Imaging Breast Cancer

  1997cites this paper
• The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.

  1997cites this paper
• Carbon-11-labeled estrogens as potential imaging agents for breast tumors.

  1996cites this paper
• Steroid Hormone Receptors as Targets for Diagnostic Imaging

  1996cites this paper
• In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.

  1996cites this paper
• Designing steroid receptor-based radiotracers to image breast and prostate tumors.

  1995cites this paper
• 6 alpha-[18F]fluoroprogesterone: synthesis via halofluorination-oxidation, receptor binding and tissue distribution.

  1995cites this paper
• Synthesis of C-6 fluoroandrogens: evaluation of ligands for tumor receptor imaging.

  1995cites this paper
• 6α-[18F]Fluoroprogesterone: Synthesis via halofluorination-oxidation, receptor binding and tissue distribution

  1995cites this paper